TNFRSF17 and acute myeloid leukemia: Of note, CD33 and BCMA are specifically present in acute myeloid leukemia and in plasma cells and some B cells [16], respectively, so the payload mechanism of action could produce an ALT/AST increase or corneal toxicity.